Search results
From Proteopedia
You searched for JMedChem:1
There is no page with the exact title "JMedChem:1". The search results for "JMedChem:1" are displayed below. You can create a page titled JMedChem:1 (by clicking on the red link).
For more information about searching Proteopedia, see Help.
Showing below up to 20 results starting with #1.
View (previous 20) (next 20) (20 | 50 | 100 | 250 | 500)
Article title matches
- Journal:JMedChem:1 (2,933 bytes)
1: ...' size='450' side='right' scene='Journal:JMEDCHEM:1/Cv/2' caption=''>
3: ...ssa Degani, and Joel L. Sussman</big> <ref>PMID: 21473635</ref>
7: ...all these three complexes:</scene> E2/ERα-LBD ([[1ere]]), OHT/ERα-LBD ([[3ert]]) and EPTA-Eu/ERα-L...
Page text matches
- 9big (3,481 bytes)
2: ==Stat6 bound to degrader AK-1690==
5: <table><tr><td colspan='2'>[[9big]] is a 1 chain structure with sequence from [https://en.wi...
6: ... diffraction, [[Resolution|Resolution]] 3.304Å</td></tr>
7: ...othiophen-5-yl)di(fluoro)methyl]phosphonic+acid'>A1AQQ</scene></td></tr>
14: ...des a structural basis for their interactions. AK-1690 is a powerful tool with which to investigate t... - 8z5j (6,253 bytes)
5: <table><tr><td colspan='2'>[[8z5j]] is a 1 chain structure with sequence from [https://en.wi...
6: ...ay diffraction, [[Resolution|Resolution]] 2.8Å</td></tr>
10: ...n linked to exposure to asbestos.<ref>PMID:11464291</ref>
12: ...8086858</ref> <ref>PMID:18957423</ref> <ref>PMID:21262353</ref>
15: ... can enhance antigen presentation and activate cDC1 cells, delivering a potential strategy for boosti... - 9n3n (5,516 bytes)
6: ...y diffraction, [[Resolution|Resolution]] 2.75Å</td></tr>
7: ...ORIDE+ION'>CL</scene>, <scene name='pdbligand=EDO:1,2-ETHANEDIOL'>EDO</scene>, <scene name='pdbligand...
11: ...6</ref> <ref>PMID:21917714</ref> <ref>PMID:22269951</ref>
14: ...ed genes in cancer, occurring in approximately 10-15% of all human cancer. We have previously describ...
16: ...s.jmedchem.4c03067. PMID:40035511<ref>PMID:40035511</ref> - 9n3o (3,894 bytes)
2: ...T5:MEP50 in complex with MTA and oxamide compound 14==
6: ...y diffraction, [[Resolution|Resolution]] 2.37Å</td></tr>
7: ...ORIDE+ION'>CL</scene>, <scene name='pdbligand=EDO:1,2-ETHANEDIOL'>EDO</scene>, <scene name='pdbligand...
11: ...otic nuage.<ref>PMID:11756452</ref> <ref>PMID:23071334</ref>
14: ...ed genes in cancer, occurring in approximately 10-15% of all human cancer. We have previously describ... - 9n3p (5,404 bytes)
3: ...t'caption='[[9n3p]], [[Resolution|resolution]] 2.51Å' scene=''>
6: ...y diffraction, [[Resolution|Resolution]] 2.51Å</td></tr>
7: ...ORIDE+ION'>CL</scene>, <scene name='pdbligand=EDO:1,2-ETHANEDIOL'>EDO</scene>, <scene name='pdbligand...
11: ...6</ref> <ref>PMID:21917714</ref> <ref>PMID:22269951</ref>
14: ...ed genes in cancer, occurring in approximately 10-15% of all human cancer. We have previously describ... - 9n3q (5,364 bytes)
2: ...5:MEP50 in complex with MTA and oxamide compound 51==
6: ...y diffraction, [[Resolution|Resolution]] 2.54Å</td></tr>
7: ...tamide'>A1BV2</scene>, <scene name='pdbligand=EDO:1,2-ETHANEDIOL'>EDO</scene>, <scene name='pdbligand...
11: ...6</ref> <ref>PMID:21917714</ref> <ref>PMID:22269951</ref>
14: ...ed genes in cancer, occurring in approximately 10-15% of all human cancer. We have previously describ... - 9n3r (5,425 bytes)
6: ...y diffraction, [[Resolution|Resolution]] 2.47Å</td></tr>
7: ...ORIDE+ION'>CL</scene>, <scene name='pdbligand=EDO:1,2-ETHANEDIOL'>EDO</scene>, <scene name='pdbligand...
11: ...6</ref> <ref>PMID:21917714</ref> <ref>PMID:22269951</ref>
14: ...ed genes in cancer, occurring in approximately 10-15% of all human cancer. We have previously describ...
16: ...s.jmedchem.4c03067. PMID:40035511<ref>PMID:40035511</ref> - 9iv5 (3,960 bytes)
3: ...ight'caption='[[9iv5]], [[Resolution|resolution]] 1.59Å' scene=''>
5: <table><tr><td colspan='2'>[[9iv5]] is a 1 chain structure with sequence from [https://en.wi...
6: ...y diffraction, [[Resolution|Resolution]] 1.59Å</td></tr>
7: ...razol-4-yl)phenyl]-1~{H}-imidazo[4,5-b]pyridine'>A1D95</scene>, <scene name='pdbligand=CL:CHLORIDE+IO...
11: ...usion protein.<ref>PMID:12543779</ref> <ref>PMID:11733348</ref> - 9itd (4,463 bytes)
2: ==Human MTHFD1 in complex with compound 16a==
6: ...y diffraction, [[Resolution|Resolution]] 2.28Å</td></tr>
7: ...o]-4-(1~{H}-1,2,3,4-tetrazol-5-yl)butanoic+acid'>A1L22</scene>, <scene name='pdbligand=NAP:NADP+NICOT...
11: ...cancer (CRC) [MIM:[https://omim.org/entry/114500 114500].
13: [https://www.uniprot.org/uniprot/C1TC_HUMAN C1TC_HUMAN] - 9iuo (4,445 bytes)
2: ==Human MTHFD1 in complex with compound 16d==
6: ...y diffraction, [[Resolution|Resolution]] 2.09Å</td></tr>
7: ...3-methyl-phenyl]carbonylamino]pentanedioic+acid'>A1L25</scene>, <scene name='pdbligand=NAP:NADP+NICOT...
11: ...cancer (CRC) [MIM:[https://omim.org/entry/114500 114500].
13: [https://www.uniprot.org/uniprot/C1TC_HUMAN C1TC_HUMAN] - 8bo7 (5,203 bytes)
3: ...ight'caption='[[8bo7]], [[Resolution|resolution]] 1.25Å' scene=''>
5: <table><tr><td colspan='2'>[[8bo7]] is a 1 chain structure with sequence from [https://en.wi...
6: ...y diffraction, [[Resolution|Resolution]] 1.25Å</td></tr>
7: ...me='pdbligand=TRS:2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL'>TRS</scene></td></tr>
11: ...322133</ref> <ref>PMID:21999818</ref> <ref>PMID:22159456</ref> - 9f2p (4,238 bytes)
2: ...th a fluorenone-based small molecule inhibitor at 1.36A resolution==
3: ...ight'caption='[[9f2p]], [[Resolution|resolution]] 1.36Å' scene=''>
5: <table><tr><td colspan='2'>[[9f2p]] is a 1 chain structure with sequence from [https://en.wi...
6: ...y diffraction, [[Resolution|Resolution]] 1.36Å</td></tr>
7: ...ylidenefluoren-4-yl)carbonylamino]ethanoic+acid'>A1H9C</scene>, <scene name='pdbligand=DMS:DIMETHYL+S... - 9f2q (4,314 bytes)
2: ...droisoquinoline-based small molecule inhibitor at 1.2A resolution==
3: ...ight'caption='[[9f2q]], [[Resolution|resolution]] 1.20Å' scene=''>
5: <table><tr><td colspan='2'>[[9f2q]] is a 1 chain structure with sequence from [https://en.wi...
6: ...ay diffraction, [[Resolution|Resolution]] 1.2Å</td></tr>
7: ...ylidenefluoren-4-yl)carbonylamino]ethanoic+acid'>A1H9B</scene>, <scene name='pdbligand=CL:CHLORIDE+IO... - 9f2v (7,569 bytes)
3: ...ht'caption='[[9f2v]], [[Resolution|resolution]] 2.19Å' scene=''>
6: ... diffraction, [[Resolution|Resolution]] 2.191Å</td></tr>
7: ...luoranyl-2-oxidanylidene-pyridin-3-yl]carbamate'>A1H9E</scene></td></tr>
11: ...guanosine cap is a prerequisite for binding of nsp16. Therefore plays an essential role in viral mRNA...
14: ...d pronounced antiviral activity with an EC(50) of 1.6 muM and was stable in plasma and microsomes. Th... - 9f2x (7,561 bytes)
3: ...ight'caption='[[9f2x]], [[Resolution|resolution]] 1.90Å' scene=''>
6: ...ay diffraction, [[Resolution|Resolution]] 1.9Å</td></tr>
7: ...an-2-yl]-3-oxidanylidene-pyrazin-2-yl]carbamate'>A1H9D</scene></td></tr>
11: ...guanosine cap is a prerequisite for binding of nsp16. Therefore plays an essential role in viral mRNA...
14: ...d pronounced antiviral activity with an EC(50) of 1.6 muM and was stable in plasma and microsomes. Th... - 9f39 (7,525 bytes)
5: <table><tr><td colspan='2'>[[9f39]] is a 1 chain structure with sequence from [https://en.wi...
6: ...y diffraction, [[Resolution|Resolution]] 2.45Å</td></tr>
7: ...~{S})-2-oxidanylidenepyrrolidin-3-yl]butanamide'>A1H9Y</scene></td></tr>
11: ...guanosine cap is a prerequisite for binding of nsp16. Therefore plays an essential role in viral mRNA...
14: ...d pronounced antiviral activity with an EC(50) of 1.6 muM and was stable in plasma and microsomes. Th... - 9f3a (7,580 bytes)
3: ...ht'caption='[[9f3a]], [[Resolution|resolution]] 2.15Å' scene=''>
6: ...y diffraction, [[Resolution|Resolution]] 2.15Å</td></tr>
7: ...luoranyl-2-oxidanylidene-pyridin-3-yl]carbamate'>A1H9Z</scene></td></tr>
11: ...guanosine cap is a prerequisite for binding of nsp16. Therefore plays an essential role in viral mRNA...
14: ...d pronounced antiviral activity with an EC(50) of 1.6 muM and was stable in plasma and microsomes. Th... - 7npy (3,340 bytes)
2: ...DOMAIN OF HUMAN BRD2 WITH 6-benzyl-N2-methyl-N4-((1S,2S)-2-methylcyclopropyl)pyridine-2,4-dicarboxami...
3: ...ight'caption='[[7npy]], [[Resolution|resolution]] 1.60Å' scene=''>
6: ... diffraction, [[Resolution|Resolution]] 1.601Å</td></tr>
7: ..., <scene name='pdbligand=UL5:~{N}2-methyl-~{N}4-[(1~{S},2~{S})-2-methylcyclopropyl]-6-(phenylmethyl)p...
12: ...d selective for BD2 over BD1 (Brd4 data) with >1 mg/mL solubility in FaSSIF media. 36 represents a... - 7nq0 (3,484 bytes)
2: ...BRD2 WITH oxabicyclo(hexan-6-yl)-N2-methyl-6-((S)-1-phenylethyl)pyridine-2,4-dicarboxamide==
3: ...ight'caption='[[7nq0]], [[Resolution|resolution]] 1.30Å' scene=''>
6: ...ay diffraction, [[Resolution|Resolution]] 1.3Å</td></tr>
7: ...,5~{S})-3-oxabicyclo[3.1.0]hexan-6-yl]-6-[(1~{S})-1-phenylethyl]pyridine-2,4-dicarboxamide'>ULN</scen...
12: ...d selective for BD2 over BD1 (Brd4 data) with >1 mg/mL solubility in FaSSIF media. 36 represents a... - 9bfv (7,646 bytes)
2: ==Tri-complex of Compound-19, KRAS G12C, and CypA==
3: ...ight'caption='[[9bfv]], [[Resolution|resolution]] 1.20Å' scene=''>
6: ...ay diffraction, [[Resolution|Resolution]] 1.2Å</td></tr>
7: ...lpyrrolidine-3-carboxamide+(non-preferred+name)'>A1AOV</scene>, <scene name='pdbligand=GNP:PHOSPHOAMI...
11: ... syndrome) [MIM:[https://omim.org/entry/115150 115150]; also known as cardio-facio-cutaneous syndrome...
View (previous 20) (next 20) (20 | 50 | 100 | 250 | 500)